Go to Top

2019 Annual Conference

Register Now

PROGRAM CO-CHAIRS

Rita Selby, MBBS FRCPC MSc and Deborah Siegal, MD MSc FRCPC

MEETING OBJECTIVES

After completing this program, participants will be equipped to:

  • Incorporate the latest evidence into the management of patients with thrombotic disease
  • Effectively manage thrombosis challenges in clinical practice
  • Consider thrombosis treatment options for a variety of patient profiles

Full program agenda: Click HERE

TARGET AUDIENCE

Physicians, nurses and pharmacists involved in the management of patients with challenging medical or surgical conditions requiring personalized anticoagulant management.

ACCREDITATION

This event is an accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians & Surgeons of Canada and approved by the Canadian Cardiovascular Society. You may claim a maximum of 5.5 hours.

This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 5.50 Mainpro+ credits.

The Canadian Council on Continuing Education in Pharmacy has accredited this program for  12.32 CEUs.

To register for the program click here:   Register Now

To book a room at our special rate visit here:  Room booking.

Full program agenda: Click HERE

ACCREDITED BREAKFAST SYMPOSIUM 

Symposium Invitation

In addition to the above program, with the support of BMS-Pfizer, we are pleased to present an accredited breakfast symposium entitled Paradigm Shift: Direct Oral Anticoagulants for the Prevention and Treatment of Cancer-Associated Thrombosis

SPEAKERS

Marc Carrier, MD
Vicky Tagalakis, MD

SYMPOSIUM OBJECTIVES

After attending this program, participants will be better able to:

  • Describe the rationale for primary thromboprophylaxis in ambulatory cancer patients;
  • Apply data from recent clinical trials in clinical decision-making about primary thromboprophylaxis;
  • Discuss direct oral anticoagulants in the treatment of cancer-associated thrombosis (CAT) recognizing cancer subgroups and bleeding risk.

SYMPOSIUM ACCREDITATION

This event is an accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians & Surgeons of Canada and approved by the Canadian Cardiovascular Society. You may claim a maximum of 1 hour.

This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 1.00 Mainpro+ credits.

The Canadian Council on Continuing Education in Pharmacy has accredited this program for 1 CEU.

Full meeting agenda: Click HERE 

Download the conference Syllabus HERE